Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Ranibizumab to Treat Retinopathy of Prematurity Stage 3 Plus Disease

NCT02164604 is registered in ClinicalTrials.gov with Kantonsspital Aarau as lead sponsor.

NCT NCT02164604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02164604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Ranibizumab to Treat Retinopathy of Prematurity Stage 3 Plus Disease
Lead sponsor
Kantonsspital Aarau
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
October 31, 2013
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity